Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satish Maharaj

Showing results (1-10 of 57) with videos related to

Pageof 6
Sort By:
Ejhaem|December 18, 2024
Low-dose nivolumab for extranodal natural killer/T-cell lymphoma, nasal typeSatish Maharaj, Simone Chang
Thrombosis Research|October 2, 2018
Anti-PF4/heparin antibodies are increased in hospitalized patients with bacterial sepsisSatish Maharaj, Simone Chang
Ejhaem|October 17, 2024
Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?Satish Maharaj, Simone Chang
Heart Asia|June 6, 2018
DKA-induced Brugada phenocopy mimicking STEMIChristian Abrahim, Satish Maharaj
The American Journal of Emergency Medicine|December 3, 2014
Consideration of C-reactive protein and polyserositis in systemic lupus erythematosus presenting with cardiac symptomsSatish Maharaj, Simone Chang
Expert Review of Hematology|May 17, 2022
Procalcitonin as a diagnostic marker for infection in sickle cell diseaseSatish Maharaj, Simone Chang
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Clinical Utility of Neutrophil to Lymphocyte Ratio in Sickle Cell Disease With Vaso-Occlusive CrisisSatish Maharaj, Simone Chang
International Journal of Cardiology|December 2, 2014
Pericardial effusions in systemic lupus erythematosus - who is most likely to develop tamponade?Satish Maharaj, Simone Chang
Heart & Lung : the Journal of Critical Care|October 24, 2020
Left ventricular thrombi in malignancy: A therapeutic dilemmaMichael Brandon Omar, Satish Maharaj
Journal of Thrombosis and Haemostasis : JTH|December 31, 2020
Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: Implications for the ADAMTS-13-von Willebrand factor axisSatish Maharaj, Ruobing Xue, Adam Rojan
Pageof 6

Showing results (1-10 of 57) with videos related to

Sort By:
Pageof 6
Ejhaem|December 18, 2024
Low-dose nivolumab for extranodal natural killer/T-cell lymphoma, nasal typeSatish Maharaj, Simone Chang
Thrombosis Research|October 2, 2018
Anti-PF4/heparin antibodies are increased in hospitalized patients with bacterial sepsisSatish Maharaj, Simone Chang
Ejhaem|October 17, 2024
Acute myeloid leukemia presenting with hepatic dysfunction: Should induction be dose reduced?Satish Maharaj, Simone Chang
Heart Asia|June 6, 2018
DKA-induced Brugada phenocopy mimicking STEMIChristian Abrahim, Satish Maharaj
The American Journal of Emergency Medicine|December 3, 2014
Consideration of C-reactive protein and polyserositis in systemic lupus erythematosus presenting with cardiac symptomsSatish Maharaj, Simone Chang
Expert Review of Hematology|May 17, 2022
Procalcitonin as a diagnostic marker for infection in sickle cell diseaseSatish Maharaj, Simone Chang
Hematology/Oncology and Stem Cell Therapy|January 12, 2023
Clinical Utility of Neutrophil to Lymphocyte Ratio in Sickle Cell Disease With Vaso-Occlusive CrisisSatish Maharaj, Simone Chang
International Journal of Cardiology|December 2, 2014
Pericardial effusions in systemic lupus erythematosus - who is most likely to develop tamponade?Satish Maharaj, Simone Chang
Heart & Lung : the Journal of Critical Care|October 24, 2020
Left ventricular thrombi in malignancy: A therapeutic dilemmaMichael Brandon Omar, Satish Maharaj
Journal of Thrombosis and Haemostasis : JTH|December 31, 2020
Thrombotic thrombocytopenic purpura (TTP) response following COVID-19 infection: Implications for the ADAMTS-13-von Willebrand factor axisSatish Maharaj, Ruobing Xue, Adam Rojan
Pageof 6